DISC-0974
A Phase 1b/2a Open-label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DISC-0974 in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
More Information
- Trial Status
- Accepting patients
- Trial Phase
- Phase 1/2
- Enrollment
- 150 patients (estimated)
- Sponsors
- Disc Medicine, Inc
- Tags
- Monoclonal Antibody, Hemojuvelin (HJV), Monotherapy, Randomization
- Trial Type
- Supportive
- Last Update
- 1 week ago
- SparkCures ID
- 1957
- NCT Identifier
- NCT05320198
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print this trial to share with your doctor.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.